seen from United States
seen from South Africa
seen from Kazakhstan
seen from Russia
seen from United States
seen from Malaysia
seen from United States
seen from China
seen from Türkiye
seen from Spain
seen from China
seen from China
seen from Georgia
seen from Türkiye
seen from Kazakhstan
seen from South Africa
seen from Argentina
seen from Singapore
seen from United States
seen from United States
Semler Scientific Reaches DOJ Settlement, Plans Further Bitcoin Investments
Semler Scientific (SMLR), a healthcare technology company known for its significant Bitcoin (BTC) holdings, has reached a preliminary agreement with the U.S. Department of Justice (DOJ). According to a Tuesday filing, the company is prepared to pay $29.75 million to resolve potential violations of federal anti-fraud laws related to the marketing of its flagship product, QuantaFlo. The…
The QuantaFlo system is well-suited for use in primary care offices, specialty practices and health fairs or during home assessments. With QuantaFlo PAD testing can now be performed quickly and reliably by any medical assistant and has proven at least as accurate as previous technology.
QuantaFlo™ The QuantaFlo™ System from Semler Scientific is a fast and easy test to perform that aids in the diagnosis of Peripheral Arterial Disease. It’s FDA cleared, patented and in use in doctor’s offices throughout the country. QuantaFlo™ video A brief overview of Peripheral Arterial Disease Peripheral Arterial Disease (often abbreviated as PAD) is a …
It is Easy to use and portable and it can be installed on any Windows-based PC, laptop or tablet.
There is various way of testing for the presence of PAD, one of which is the use of a system known as QuantaFlo
PAD affects millions of people and often goes undiagnosed by healthcare professionals. QuantaFlo System from Semler Scientific makes it easy to perform a reliable test.
The QuantaFlo System from Semler Scientific is a fast and easy test to perform that aids in the diagnosis of Peripheral Arterial Disease. PAD (sometimes called peripheral vascular disease) is a disease that affects the arteries, but some of the latest reports show that it affects veins as well.
QuantaFlo™ (Semler Scientific, Inc.) is a novel, noninvasive, 510K FDA approved a digital device that is used as a screening tool to measure ABI of patients at risk of PAD.
The QuantaFlo is advice and system that provides PAD test delivers fast, accurate results in around 5 minutes at the point of care when the opportunity to improve health and lower cost is the greatest.
